InsightfulValue
← Home

Novartis
Novartis

Pharma / Pharmaceuticals and Healthcare


πŸ”§ Tools

βœ… Due Diligence
πŸ“ Financial Growth

Pay attention and research significant changes from year to year values. [ ! ]

Revenue
Growth, %
Net Income
Growth, %
Operating Cash Flow
Growth, %
Free Cash Flow
Growth, %
EPS
Growth, %
EPS Diluted
Growth, %
Operating Income
Growth, %
EBIT
Growth, %
Gross Profit
Growth, %
Ten Y Revenue Growth
Per Share, %
Ten Y Net Income Growth
Per Share, %
Ten Y Operating CF Growth
Per Share, %
Ten Y Shareholders Equity Growth
Per Share, %
Five Y Revenue Growth
Per Share, %
Five Y Net Income Growth
Per Share, %
Five Y Operating CF Growth
Per Share, %
Five Y Shareholders Equity Growth
Per Share, %
Three Y Revenue Growth
Per Share, %
Three Y Net Income Growth
Per Share, %
Three Y Operating CF Growth
Per Share, %
Three Y Shareholders Equity Growth
Per Share, %
Book Value Per Share Growth, %Asset Growth, %Debt Growth, %Dividends per Share
Growth, %
Ten Y Dividend Per Share Growth
Per Share, %
Five Y Dividend Per Share Growth
Per Share, %
Three Y Dividend Per Share Growth
Per Share, %
Weighted Average Shares
Growth, %
Weighted Average Shares Diluted
Growth, %
Receivables Growth, %Inventory Growth, %R&D Expense Growth, %SGA Expenses Growth, %
2025-125.9717.79.2128.1122.4622.4817.3920.45.7234.8 -2.05 100.43 -25.8 29104.4965.54 -4.28 41.87127.3452.05 -12.55 9.813.0318.477.2846.5832.0717.76 -3.93 -3.93 33.169.547.185.88
2024-1210.84 -19.58 21.8617.94 -17.2 -17.32 48.8746.7813.7615.9140.5852.39 -25.18 20.615.5246.77 -9.87 30.69 -44.76 29.9 -27.66 -2.87 2.318.638.1334.5630.2214.97 -2.81 -2.72 -12.42 -3.21 -11.86 0.39
2023-12****************************************************************************************************************************************
2022-12****************************************************************************************************************************************
2021-12****************************************************************************************************************************************
2020-12****************************************************************************************************************************************
2019-12****************************************************************************************************************************************
2018-12****************************************************************************************************************************************
2017-12****************************************************************************************************************************************
Novartis

πŸ“Š Explore more financial growth data for Novartis!

Sign up for free or log in

πŸ‘₯ Free eBook for new users: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal